Cargando…
In-vivo monitoring of anti-folate therapy in arthritic rats using [(18)F]fluoro-PEG-folate and positron emission tomography
BACKGROUND: Folate receptor β (FRβ) is involved in facilitating cellular uptake of folates and anti-folates (such as methotrexate (MTX)). In rheumatoid arthritis, FRβ is expressed on synovial macrophages and recently has been explored as a biomarker for imaging in arthritic rats using the folate-bas...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452381/ https://www.ncbi.nlm.nih.gov/pubmed/28569209 http://dx.doi.org/10.1186/s13075-017-1325-x |
_version_ | 1783240406400499712 |
---|---|
author | Chandrupatla, Durga M. S. H. Jansen, Gerrit Vos, Ricardo Verlaan, Mariska Chen, Qingshou Low, Philip S. Windhorst, Albert D. Lammertsma, Adriaan A. van der Laken, Conny J. Molthoff, Carla F. M. |
author_facet | Chandrupatla, Durga M. S. H. Jansen, Gerrit Vos, Ricardo Verlaan, Mariska Chen, Qingshou Low, Philip S. Windhorst, Albert D. Lammertsma, Adriaan A. van der Laken, Conny J. Molthoff, Carla F. M. |
author_sort | Chandrupatla, Durga M. S. H. |
collection | PubMed |
description | BACKGROUND: Folate receptor β (FRβ) is involved in facilitating cellular uptake of folates and anti-folates (such as methotrexate (MTX)). In rheumatoid arthritis, FRβ is expressed on synovial macrophages and recently has been explored as a biomarker for imaging in arthritic rats using the folate-based positron emission tomography (PET) tracer [(18)F]fluoro-PEG-folate. The purpose of this study was to examine whether this folate tracer can also be used to monitor therapeutic efficacy of MTX in arthritic rats. METHODS: Arthritic rats received either no treatment or MTX therapy (1 mg/kg, either 2× or 4×). Healthy rats did not receive any arthritic induction or therapy. [(18)F]fluoro-PEG-folate PET-CT scans (60 min) were performed before and after MTX therapy. Following PET, the ex-vivo tissue distribution of radioactivity was determined in excised knees and multiple tissues. Synovial macrophage infiltration in knee sections was quantified by immunohistochemistry using ED1 and ED2 antibodies. RESULTS: PET scans clearly visualized increased uptake of [(18)F]fluoro-PEG-folate in arthritic knees compared with contralateral knees. Significantly lower standard uptake values (1.5-fold, p < 0.01) were observed in arthritic knees of both MTX-treated groups after therapy, approximating the levels seen in healthy rats. Consistently, ex-vivo tissue distribution demonstrated a 2–4-fold lower tracer uptake in the arthritic knee of 2× and 4× MTX-treated rats, respectively, compared with control rats. These results were corroborated with significantly reduced (2–4-fold, p < 0.01) ED1-positive and ED2-positive synovial macrophages in arthritic knees of the MTX-treated rats compared with those of the control rats. CONCLUSION: This study in arthritic rats underscores the potential and usefulness of [(18)F]fluoro-PEG-folate PET as a therapeutic monitoring tool of MTX therapy and potentially other anti-folate treatment of arthritis. |
format | Online Article Text |
id | pubmed-5452381 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-54523812017-06-01 In-vivo monitoring of anti-folate therapy in arthritic rats using [(18)F]fluoro-PEG-folate and positron emission tomography Chandrupatla, Durga M. S. H. Jansen, Gerrit Vos, Ricardo Verlaan, Mariska Chen, Qingshou Low, Philip S. Windhorst, Albert D. Lammertsma, Adriaan A. van der Laken, Conny J. Molthoff, Carla F. M. Arthritis Res Ther Research Article BACKGROUND: Folate receptor β (FRβ) is involved in facilitating cellular uptake of folates and anti-folates (such as methotrexate (MTX)). In rheumatoid arthritis, FRβ is expressed on synovial macrophages and recently has been explored as a biomarker for imaging in arthritic rats using the folate-based positron emission tomography (PET) tracer [(18)F]fluoro-PEG-folate. The purpose of this study was to examine whether this folate tracer can also be used to monitor therapeutic efficacy of MTX in arthritic rats. METHODS: Arthritic rats received either no treatment or MTX therapy (1 mg/kg, either 2× or 4×). Healthy rats did not receive any arthritic induction or therapy. [(18)F]fluoro-PEG-folate PET-CT scans (60 min) were performed before and after MTX therapy. Following PET, the ex-vivo tissue distribution of radioactivity was determined in excised knees and multiple tissues. Synovial macrophage infiltration in knee sections was quantified by immunohistochemistry using ED1 and ED2 antibodies. RESULTS: PET scans clearly visualized increased uptake of [(18)F]fluoro-PEG-folate in arthritic knees compared with contralateral knees. Significantly lower standard uptake values (1.5-fold, p < 0.01) were observed in arthritic knees of both MTX-treated groups after therapy, approximating the levels seen in healthy rats. Consistently, ex-vivo tissue distribution demonstrated a 2–4-fold lower tracer uptake in the arthritic knee of 2× and 4× MTX-treated rats, respectively, compared with control rats. These results were corroborated with significantly reduced (2–4-fold, p < 0.01) ED1-positive and ED2-positive synovial macrophages in arthritic knees of the MTX-treated rats compared with those of the control rats. CONCLUSION: This study in arthritic rats underscores the potential and usefulness of [(18)F]fluoro-PEG-folate PET as a therapeutic monitoring tool of MTX therapy and potentially other anti-folate treatment of arthritis. BioMed Central 2017-05-31 2017 /pmc/articles/PMC5452381/ /pubmed/28569209 http://dx.doi.org/10.1186/s13075-017-1325-x Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Chandrupatla, Durga M. S. H. Jansen, Gerrit Vos, Ricardo Verlaan, Mariska Chen, Qingshou Low, Philip S. Windhorst, Albert D. Lammertsma, Adriaan A. van der Laken, Conny J. Molthoff, Carla F. M. In-vivo monitoring of anti-folate therapy in arthritic rats using [(18)F]fluoro-PEG-folate and positron emission tomography |
title | In-vivo monitoring of anti-folate therapy in arthritic rats using [(18)F]fluoro-PEG-folate and positron emission tomography |
title_full | In-vivo monitoring of anti-folate therapy in arthritic rats using [(18)F]fluoro-PEG-folate and positron emission tomography |
title_fullStr | In-vivo monitoring of anti-folate therapy in arthritic rats using [(18)F]fluoro-PEG-folate and positron emission tomography |
title_full_unstemmed | In-vivo monitoring of anti-folate therapy in arthritic rats using [(18)F]fluoro-PEG-folate and positron emission tomography |
title_short | In-vivo monitoring of anti-folate therapy in arthritic rats using [(18)F]fluoro-PEG-folate and positron emission tomography |
title_sort | in-vivo monitoring of anti-folate therapy in arthritic rats using [(18)f]fluoro-peg-folate and positron emission tomography |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452381/ https://www.ncbi.nlm.nih.gov/pubmed/28569209 http://dx.doi.org/10.1186/s13075-017-1325-x |
work_keys_str_mv | AT chandrupatladurgamsh invivomonitoringofantifolatetherapyinarthriticratsusing18ffluoropegfolateandpositronemissiontomography AT jansengerrit invivomonitoringofantifolatetherapyinarthriticratsusing18ffluoropegfolateandpositronemissiontomography AT vosricardo invivomonitoringofantifolatetherapyinarthriticratsusing18ffluoropegfolateandpositronemissiontomography AT verlaanmariska invivomonitoringofantifolatetherapyinarthriticratsusing18ffluoropegfolateandpositronemissiontomography AT chenqingshou invivomonitoringofantifolatetherapyinarthriticratsusing18ffluoropegfolateandpositronemissiontomography AT lowphilips invivomonitoringofantifolatetherapyinarthriticratsusing18ffluoropegfolateandpositronemissiontomography AT windhorstalbertd invivomonitoringofantifolatetherapyinarthriticratsusing18ffluoropegfolateandpositronemissiontomography AT lammertsmaadriaana invivomonitoringofantifolatetherapyinarthriticratsusing18ffluoropegfolateandpositronemissiontomography AT vanderlakenconnyj invivomonitoringofantifolatetherapyinarthriticratsusing18ffluoropegfolateandpositronemissiontomography AT molthoffcarlafm invivomonitoringofantifolatetherapyinarthriticratsusing18ffluoropegfolateandpositronemissiontomography |